Two Clinical Cases of Secondary Neoplasia After Remission of Hodgkin’s Disease
References
- 1. Hjalgrim H, Jarrett RF. Epidemiology of Hodgkin Lymphoma. In: Engert A., Younes A. (eds) Hodgkin Lymphoma. Hematologic Malignancies. Springer, Cham, 2020.10.1007/978-3-030-32482-7_1
- 2. Westin RJ, Gibbs A, Mills RK, Neelapu SS. Hodgkin Lymphoma Untreated for Six Years Presenting with Tracheoesophageal Fistula. Volume 2012, Article ID 45790810.1155/2012/457908339541322811723
- 3. Gaudio F, Pedote P, Niccoli Asabella A, Ingravallo G, Sindaco P, Alberotanza V, Perrone T et al. Bone involvement in Hodgkin‘s lymphoma: clinical features and outcome. ActaHaematol 2018;140:178-82.10.1159/00049048930300883
- 4. Mottok A, Steidl Ch. Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies. Blood 2018;131(15):1654-65.10.1182/blood-2017-09-77263229500175
- 5. Risk Factors: Age - National Cancer Institutehttps://www.cancer.gov
- 6. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister TA, Radford JA, Rohatiner AZ, Linch DC. Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. J ClinOncol. 2011 Nov 1;29(31):4096-104.10.1200/JCO.2011.34.826821969511
- 7. Hjalgrim H, Jarrett RF. Epidemiology of Hodgkin Lymphoma. In: Engert A., Younes A. (eds) Hodgkin Lymphoma. Hematologic Malignancies. Springer, Cham, 2020.10.1007/978-3-030-32482-7_1
- 8. Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. Occurrence of Non-Hodgkin’s Lymphoma after Therapy for Hodgkin’s Disease. New England Journal of Medicine. 1979;300(9):452-8.10.1056/NEJM197903013000902366418
- 9. Schaapveld M, Aleman PMB, van Eggermond A, Janus MPC, Krol GDA, van der Maazen MWR et al. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma. N Engl J Med 2015; 373:2499-511.10.1056/NEJMoa150594926699166
- 10. Bakkach J, Mansouri M, Loudiyi A, Nourouti NG, Barakat A, Mechita MB. Secondary breast cancer after Hodgkin lymphoma: a case report and literature review. Ecancermedicalscience. 2018 Feb 14;12:810.10.3332/ecancer.2018.810582867329492104
- 11. Opstal-van Winden AWJ, de Haan HG, Hauptmann M, Schmidt MK, Broeks A, Russell NS, et al. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood. 2019 Mar 7;133(10):1130-9.10.1182/blood-2018-07-862607640533430573632
- 12. Sud A, Thomsen H, Sundquist K, Houlston S R, Hemminki K. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. J Clin Oncol. 2017;35(14):1584-90.10.1200/JCO.2016.70.9709545570528384078
- 13. Schellong G, Riepenhausen M, Ehlert K, Brämswig J, Dörffel W, Schmutzler RK, et al. Breast cancer in young women after treatment for Hodgkin‘s disease during childhood or adolescence - an observational study with up to 33-year follow-up. Dtsch Arztebl Int. 2014;111(1-2):3-9.10.3238/arztebl.2014.0003394801324565270
- 14. Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M. Risk of second breast cancer in female Hodgkin‘s lymphoma survivors: a meta-analysis. BMC Cancer. 2012;12:197.10.1186/1471-2407-12-197341658522639888
- 15. van Leeuwen FE, Ng AK. Late sequelae in Hodgkin lymphoma survivors. Hematol Oncol. 2017 Jun;35 Suppl 1:60-66.10.1002/hon.240228591411
- 16. Horst KC, Hancock SL, Ognibene G, Chen C, Advani RH, Rosenberg SA, Donaldson SS, Hoppe RT. Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. Ann Oncol. 2014 Apr;25(4):848-51.10.1093/annonc/mdu01724608191
- 17. Engert A, Plütschow A, Eichth H, Lohri A, Dörken B, Borchmann P et al. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin‘s Lymphoma. N Engl J Med 2010;363:640-52.10.1056/NEJMoa100006720818855
DOI: https://doi.org/10.2478/jbcr-2022-0012 | Journal eISSN: 1313-9053
Language: English
Page range: 83 - 86
Submitted on: Dec 1, 2021
Accepted on: Feb 10, 2022
Published on: Jul 13, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2022 Vanya S. Popova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.